FDA uncovers falsified research data from contractor Cetero

07/26/2011 | Reuters

Drugmakers might need to re-evaluate bioanalytical data provided by Cetero Research to support new-drug applications between April 2005 and June 2010, the FDA said. The agency said it uncovered falsified clinical data during May and December inspections of the contract research organization's Houston facility.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY